TC
CRL icon

TradeLink Capital’s Charles River Laboratories CRL Stock Holding History

TradeLink Capital’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,666
Closed -$196K – 262
2014
Q2 		$196K Buy
+3,666
New +$201K 0.18% 185

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TradeLink Capital's CRL Position: Q3 2014 in Review

TradeLink Capital sold out of Charles River Laboratories (CRL) in Q3 2014, closing a stake of 3,666 shares — an estimated $196K sold.

TradeLink Capital first reported a position in CRL in Q2 2014 and held it in 1 quarter. The position peaked at $196K in Q2 2014. 255 funds tracked by Wall St. Rank hold CRL as of Q3 2014.

  • TradeLink Capital reported no remaining Charles River Laboratories position as of Q3 2014 after selling out during the quarter.
  • TradeLink Capital sold 3,666 Charles River Laboratories shares in Q3 2014, an estimated $196K.
  • TradeLink Capital first reported a position in Charles River Laboratories in Q2 2014 and held it in 1 quarter.
  • TradeLink Capital's Charles River Laboratories position peaked at $196K in Q2 2014.
  • 255 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2014.

Based on TradeLink Capital's 13F filing for Q3 2014, filed 27 Oct 2014.